Biopersistence of potassium hexatitanate in inhalation and intratracheal instillation studies

Inhalation Toxicology

Volumn 23, Issue 4, 2011, Pages 196-204

  Yamamoto, Makoto ^a   Oyabu, Takako ^a   Morimoto, Yasuo ^a   Ogami, Akira ^a   Kadoya, Chikara ^a   Nishi, Ken Ichiro ^a   Todoroki, Motoi ^a   Myojo, Toshihiko ^a   Tanaka, Isamu ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Biopersistence; inhalation; instillation; Potassium Hexatitanate

Indexed keywords

CHEMICAL AGENT; POTASSIUM HEXATITANATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; EXPOSURE; HISTOPATHOLOGY; LUNG BURDEN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, INHALATION; ANIMALS; HYDROGEN-ION CONCENTRATION; INHALATION EXPOSURE; LUNG; MALE; PARTICLE SIZE; POTASSIUM COMPOUNDS; RATS; RATS, WISTAR; TITANIUM; TRACHEA;

RATTUS;

EID: 79953665124     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2011.558935     Document Type: Article

References (18)

1. Bellmann B, Schaefer HA, Muhle H. 2010. Impact of variations in the chemical composition of vitreous mineral fbers on biopersistence in rat lungs and consequences for regulation. Inhal Toxicol 22:817-827.
2. Bernstein DM, Donaldson K, Decker U, Gaering S, Kunzendorf P, Chevalier J, Holm SE. 2008. A biopersistence study following exposure to chrysotile asbestos alone or in combination with fne particles. Inhal Toxicol 20:1009-1028.
3. Bernstein DM, Morscheidt C, Grimm HG, Teichert U. 1996. Te evaluation of soluble fbers using the inhalation biopersistence model, a nine fber comparison. Inhal Toxicol 8:345-385. (Pubitemid 26263529)
4. European Community. 1997. Commission Directive 97/69/EC, December 5, 1997, adapting to Council Directive 67/548/EEC Ofcial journal No. L343, 13/12/1997 P. 0019-0024.
5. Hesterberg TW, Hart GA, Chevalier J, Miiller WC, Hamilton RD, Bauer J, Tevenaz P. 1998a. Te importance of fber biopersistence and lung dose in determining the chronic inhalation efects of X607, RCF1, and chrysotile asbestos in rats. Toxicol Appl Pharmacol 153:68-82. (Pubitemid 28563891)
6. Hesterberg TW, Chase G, Axten C, Miller WC, Musselman RP, Kamstrup O, Hadley J, Morscheidt C, Bernstein DM, Tevenaz P. 1998b. Biopersistence of synthetic vitreous fbers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharmacol 151:262-275. (Pubitemid 128421790)
7. IARC. 2002. Man-made Vitreous Fibres. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 81: pp. 181-339.
8. Muhle H, Bellmann B, Pott F. 1994. Comparative investigation of biodurability of mineral fbers in the rat lung. Environ Health Perspect 102 (Suppl 5):163-168. http://ehp.niehs.nih.gov/members/1994/Suppl-5/muhle-full.html (Accessed December 25, 2010.) (Pubitemid 24364844)
9. Oberdörster G. 2002. Toxicokinetics and efects of fbrous and nonfbrous particles. Inhal Toxicol 14:29-56. (Pubitemid 34094359)
10. Ogami A, Morimoto Y Myojo T, Oyabu T, Murakami M, Todoroki M, Nishi K, Kadoya C, Yamamoto M, Tanaka I. 2009. Pathological features of diferent sizes of nickel oxide following intratracheal instillation in rats. Inhal Toxicol 21:812-818.
11. Ogami A, Morimoto Y Yamato H, Oyabu T, Kajiwara T, Tanaka I. 2004. Pattern of histopathological change determined by the point counting method and its application for the hazard assessment of respirable dust. Inhal Toxicol 16:793-800. (Pubitemid 39258112)
12. Oyabu T, Yamato H, Ogami A, Morimoto Y Akiyama I, Ishimatsu S, Hori H, Tanaka I. 2006. Te efect of lung burden on biopersistence and pulmonary efects in rats exposed to potassium octatitanate whiskers by intratracheal instillation. J Occup Health 48:44-48.
13. Oyabu T, Ishimatsu S, Yamato H, Morimoto Y Tsuda T, Hori H, Tanaka I, Baba Y 1996. Biopersistence of limestone in rat lung by intratracheal instillation. JJTOM 44:559-562 (in Japanese).
14. Oyabu T, Ogami A, Morimoto Y Myojo T, Murakami M, Yamato H, Tanaka I. 2008. Simple fow-through solubility measurement apparatus and its efectiveness for hazard assessment of particles/fbers. J Occup Health 50:279-282.
15. Sakai S, Inada K, Tanaka AK, Kelly DP, Sykes GP, Lee KP. 2010. Inhalation toxicity study of disk-shaped potassium octatitanate particles (terracess TF) in rats following 90 days of aerosol exposure. Inhal Toxicol 22:56-68.
16. Tanaka I, Akiyama T. 1984. Fibrous particle generator for inhalation toxicity studies. Ann Occup Hyg 31:157.
17. Yamato H, Hori H, Tanaka I, Higashi T, Morimoto Y, Kido M. 1994. Retention and clearance of inhaled ceramic fbres in rat lungs and development of a dissolution model. Occup Environ Med 51:275-280. (Pubitemid 24135745)
18. Warheit DB, Webb TR, Reed KL, Hansen JF, Kennedy GL Jr. 2003. Four-week inhalation toxicity study in rats with nylon respirable fbers: rapid lung clearance. Toxicology 192:189-210. (Pubitemid 37311411)